• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The lost correlation between heat shock protein 70 (HSPA1A) and plasminogen activator inhibitor-1 in patients with type 2 diabetes and albuminuria.2型糖尿病合并蛋白尿患者中热休克蛋白70(HSPA1A)与纤溶酶原激活物抑制剂-1之间相关性的丧失。
Cell Stress Chaperones. 2016 Mar;21(2):361-5. doi: 10.1007/s12192-015-0634-8. Epub 2015 Dec 4.
2
Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.科威特高脂血症患者的脂蛋白(a)、组织纤溶酶原激活物和纤溶酶原激活物抑制剂1水平
Eur J Clin Invest. 1997 May;27(5):380-6. doi: 10.1046/j.1365-2362.1997.1230671.x.
3
The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.2型糖尿病正常白蛋白尿和微量白蛋白尿患者中凝血酶激活的纤溶抑制物(TAFI)、组织型纤溶酶原激活物(t-PA)、纤溶酶原激活物抑制剂-1(PAI-1)与纤维蛋白肽A和Bβ1-42(F1 + 2)之间的关系。
Blood Coagul Fibrinolysis. 2011 Sep;22(6):493-8. doi: 10.1097/MBC.0b013e328346f8ca.
4
Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.纤溶酶原激活物抑制剂-1基因多态性与2型糖尿病肾病的关联。
Ren Fail. 2016;38(1):157-62. doi: 10.3109/0886022X.2015.1089464. Epub 2015 Nov 29.
5
Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.2型糖尿病患者后代纤溶酶原激活物抑制剂-1活性增加:与血浆胰岛素水平无关。
Diabetes Care. 2000 Jan;23(1):88-92. doi: 10.2337/diacare.23.1.88.
6
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.血脂异常中,凝血因子VIIc水平与组织因子途径抑制物降低及纤溶酶原激活物抑制物-1升高相关。
Arterioscler Thromb Vasc Biol. 1996 Jan;16(1):77-81. doi: 10.1161/01.atv.16.1.77.
7
Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.纤溶酶原激活物抑制剂(PAI-1)活性在患有非胰岛素依赖型(2型)糖尿病的亚洲和白种人受试者中升高,但在糖耐量受损(IGT)的受试者或非糖尿病亚洲人中并未升高。
Diabet Med. 1996 Jan;13(1):59-64. doi: 10.1002/(SICI)1096-9136(199601)13:1<59::AID-DIA2>3.0.CO;2-Z.
8
Heat shock protein 70 and albuminuria in patients with type 2 diabetes: a matched case control study.2 型糖尿病患者的热休克蛋白 70 和蛋白尿:一项匹配的病例对照研究。
Cell Stress Chaperones. 2013 Nov;18(6):815-9. doi: 10.1007/s12192-013-0435-x. Epub 2013 May 17.
9
Plasma t-PA and PAI-1 antigen concentrations in non-insulin dependent diabetic patients: implication for diabetic retinopathy.
Diabetes Res Clin Pract. 1994 Jan;22(2-3):123-8. doi: 10.1016/0168-8227(94)90045-0.
10
Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.2型糖尿病患者基质金属蛋白酶-3活性与肾小球滤过率及蛋白尿状态之间的关联
Iran J Kidney Dis. 2018 Jan;12(1):40-47.

引用本文的文献

1
Relationship between advanced glycation end-products and advanced oxidation protein products in patients with type 2 diabetes with and without albuminuria: A cross-sectional survey.2型糖尿病伴或不伴蛋白尿患者中晚期糖基化终产物与晚期氧化蛋白产物的关系:一项横断面调查。
Health Sci Rep. 2024 Sep 29;7(10):e70057. doi: 10.1002/hsr2.70057. eCollection 2024 Oct.
2
Co-differential genes between DKD and aging: implications for a diagnostic model of DKD.糖尿病肾病与衰老之间的共同差异基因:对糖尿病肾病诊断模型的启示
PeerJ. 2024 Feb 29;12:e17046. doi: 10.7717/peerj.17046. eCollection 2024.
3
Absence of a positive correlation between CRP and leptin in rheumatoid arthritis.类风湿关节炎中C反应蛋白与瘦素之间不存在正相关。
Heliyon. 2016 Dec 5;2(12):e00205. doi: 10.1016/j.heliyon.2016.e00205. eCollection 2016 Dec.

本文引用的文献

1
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.估算肾小球滤过率和尿白蛋白排泄率对心血管结局的预测作用:个体参与者数据的协作荟萃分析。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25. doi: 10.1016/S2213-8587(15)00040-6. Epub 2015 May 28.
2
Increased plasma levels of heat shock protein 70 associated with subsequent clinical conversion to mild cognitive impairment in cognitively healthy elderly.血浆中热休克蛋白70水平升高与认知功能正常的老年人随后临床转化为轻度认知障碍有关。
PLoS One. 2015 Mar 13;10(3):e0119180. doi: 10.1371/journal.pone.0119180. eCollection 2015.
3
Analysis of serum heat shock protein 70 (HSPA1A) concentrations for diagnosis and disease activity monitoring in patients with rheumatoid arthritis.类风湿关节炎患者血清热休克蛋白70(HSPA1A)浓度用于诊断及疾病活动监测的分析
Cell Stress Chaperones. 2015 May;20(3):537-43. doi: 10.1007/s12192-015-0578-z. Epub 2015 Mar 6.
4
Appearance of leptin-HSP70 correlation, in type 2 diabetes.2型糖尿病中瘦素与热休克蛋白70的相关性表现。
Meta Gene. 2013 Oct 8;1:1-7. doi: 10.1016/j.mgene.2013.09.002. eCollection 2013 Dec.
5
Manual or automated sphygmomanometer? A historical cohort to quantify measurement bias in blood pressure recording.手动还是自动血压计?一项用于量化血压记录中测量偏差的历史性队列研究。
J Clin Hypertens (Greenwich). 2014 Oct;16(10):716-21. doi: 10.1111/jch.12400. Epub 2014 Sep 8.
6
Inflammatory processes in renal fibrosis.肾脏纤维化中的炎症过程。
Nat Rev Nephrol. 2014 Sep;10(9):493-503. doi: 10.1038/nrneph.2014.114. Epub 2014 Jul 1.
7
Epigenetics of diabetic complications.糖尿病并发症的表观遗传学
Expert Rev Endocrinol Metab. 2010 Jan;5(1):137-148. doi: 10.1586/eem.09.54.
8
Heat shock protein 70 and albuminuria in patients with type 2 diabetes: a matched case control study.2 型糖尿病患者的热休克蛋白 70 和蛋白尿:一项匹配的病例对照研究。
Cell Stress Chaperones. 2013 Nov;18(6):815-9. doi: 10.1007/s12192-013-0435-x. Epub 2013 May 17.
9
The lost correlation between leptin and CRP in type 2 diabetes.2 型糖尿病中瘦素与 CRP 失去相关性。
Eur Cytokine Netw. 2013 Mar;24(1):53-9. doi: 10.1684/ecn.2013.0329.
10
Heat shock protein 70: roles in multiple sclerosis.热休克蛋白 70:多发性硬化症中的作用。
Mol Med. 2012 Sep 7;18(1):1018-28. doi: 10.2119/molmed.2012.00119.

2型糖尿病合并蛋白尿患者中热休克蛋白70(HSPA1A)与纤溶酶原激活物抑制剂-1之间相关性的丧失。

The lost correlation between heat shock protein 70 (HSPA1A) and plasminogen activator inhibitor-1 in patients with type 2 diabetes and albuminuria.

作者信息

Nargesi Arash Aghajani, Shalchi Majid, Nargesi Reihaneh Aghajani, Sadeghpour Niloofar, Zarifkar Mitra, Mozaffari Majid, Imani Mehrnaz, Esteghamati Alireza, Nakhjavani Manouchehr

机构信息

Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, P.O. Box: 13145-784, Tehran, Iran.

Department of Orthodontics, Faculty of Dentistry, Guilan University of Medical Sciences, Rasht, Guilan, Iran.

出版信息

Cell Stress Chaperones. 2016 Mar;21(2):361-5. doi: 10.1007/s12192-015-0634-8. Epub 2015 Dec 4.

DOI:10.1007/s12192-015-0634-8
PMID:26637413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4786530/
Abstract

We aimed to study the relation between plasma levels of stress-induced heat shock protein 70 (HSPA1A) with plasminogen activator inhibitor-1 (PAI-1) and high-density lipoprotein cholesterol (HDL-C), apolipoprotein A1 (Apo-A1), and HDL-C/Apo-A1 ratio. In a matched case-control study on patients with diabetes (40 patients with albuminuria and 40 without albuminuria matched for age, sex, and body mass index), we observed that plasma levels of HSPA1A and PAI-1 are increased in patients with albuminuria (0.55 ± 0.02 vs. 0.77 ± 0.04 ng/ml, p value <0.001 for HSPA1A; 25.9 ± 2 vs. 31.8 ± 2.4 ng/ml, p value <0.05 for PAI-1). There was a significant correlation between HSPA1A and PAI-1 in diabetic patients without albuminuria (r = 0.28; p value = 0.04), but not in those with albuminuria (r = 0.07; p value = 0.63). No association was found between HSPA1A and HDL-C, between HSPA1A and Apo-A1, or between HSPA1A and HDL-C/Apo-A1 ratio. We concluded that there is a direct correlation between plasma HSPA1A and PAI-1 levels in patients with diabetes, which is lost when they develop albuminuria.

摘要

我们旨在研究应激诱导的热休克蛋白70(HSPA1A)的血浆水平与纤溶酶原激活物抑制剂-1(PAI-1)、高密度脂蛋白胆固醇(HDL-C)、载脂蛋白A1(Apo-A1)以及HDL-C/Apo-A1比值之间的关系。在一项针对糖尿病患者的配对病例对照研究中(40例蛋白尿患者和40例无蛋白尿患者,根据年龄、性别和体重指数进行配对),我们观察到蛋白尿患者的HSPA1A和PAI-1血浆水平升高(HSPA1A:0.55±0.02对0.77±0.04 ng/ml,p值<0.001;PAI-1:25.9±2对31.8±2.4 ng/ml,p值<0.05)。在无蛋白尿的糖尿病患者中,HSPA1A与PAI-1之间存在显著相关性(r = 0.28;p值 = 0.04),但在有蛋白尿的患者中无相关性(r = 0.07;p值 = 0.63)。未发现HSPA1A与HDL-C之间、HSPA1A与Apo-A1之间或HSPA1A与HDL-C/Apo-A1比值之间存在关联。我们得出结论,糖尿病患者血浆HSPA1A与PAI-1水平之间存在直接相关性,当他们出现蛋白尿时这种相关性消失。